Iraj Esfandiarpour

499 total citations
27 papers, 323 citations indexed

About

Iraj Esfandiarpour is a scholar working on Dermatology, Epidemiology and Rheumatology. According to data from OpenAlex, Iraj Esfandiarpour has authored 27 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Dermatology, 10 papers in Epidemiology and 7 papers in Rheumatology. Recurrent topics in Iraj Esfandiarpour's work include Research on Leishmaniasis Studies (7 papers), Cutaneous lymphoproliferative disorders research (5 papers) and Nail Diseases and Treatments (4 papers). Iraj Esfandiarpour is often cited by papers focused on Research on Leishmaniasis Studies (7 papers), Cutaneous lymphoproliferative disorders research (5 papers) and Nail Diseases and Treatments (4 papers). Iraj Esfandiarpour collaborates with scholars based in Iran and India. Iraj Esfandiarpour's co-authors include Saeedeh Farajzadeh, Afsáneh Alavi, Shahriar Dabiri, Hamed Hosseini, Amireh Heshmatkhah, Saman Mohammadi, Alireza Fekri, Elham Mohebbi, Mahshid Mostafavi and Seyyed Amin Ayatollahi Mousavi and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Dermatology and Pediatric Dermatology.

In The Last Decade

Iraj Esfandiarpour

23 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iraj Esfandiarpour Iran 10 124 123 97 82 43 27 323
Zabihollah Shahmoradi Iran 13 40 0.3× 99 0.8× 174 1.8× 94 1.1× 39 0.9× 50 371
Orhan Özgöztaşı Türkiye 10 137 1.1× 58 0.5× 183 1.9× 99 1.2× 42 1.0× 14 360
A.J. Kanwar India 14 21 0.2× 319 2.6× 168 1.7× 83 1.0× 106 2.5× 36 502
Robert Guy United Kingdom 12 34 0.3× 114 0.9× 310 3.2× 52 0.6× 49 1.1× 15 521
YogeshS Marfatia India 10 10 0.1× 136 1.1× 83 0.9× 63 0.8× 93 2.2× 22 328
Wendy C. Cantrell United States 7 18 0.1× 102 0.8× 448 4.6× 93 1.1× 34 0.8× 10 496
V. Goffin Belgium 12 16 0.1× 52 0.4× 326 3.4× 52 0.6× 19 0.4× 28 439
Izabela Chudzicka-Strugała Poland 8 54 0.4× 7 0.1× 75 0.8× 40 0.5× 60 1.4× 18 292
Ganga Sirimanna Sri Lanka 6 182 1.5× 35 0.3× 97 1.0× 117 1.4× 8 0.2× 7 312
Véronique Goffin Belgium 10 12 0.1× 35 0.3× 190 2.0× 54 0.7× 37 0.9× 22 381

Countries citing papers authored by Iraj Esfandiarpour

Since Specialization
Citations

This map shows the geographic impact of Iraj Esfandiarpour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iraj Esfandiarpour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iraj Esfandiarpour more than expected).

Fields of papers citing papers by Iraj Esfandiarpour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iraj Esfandiarpour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iraj Esfandiarpour. The network helps show where Iraj Esfandiarpour may publish in the future.

Co-authorship network of co-authors of Iraj Esfandiarpour

This figure shows the co-authorship network connecting the top 25 collaborators of Iraj Esfandiarpour. A scholar is included among the top collaborators of Iraj Esfandiarpour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iraj Esfandiarpour. Iraj Esfandiarpour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farajzadeh, Saeedeh, et al.. (2019). Efficacy of combination therapy of pimecrolimus 1% cream and mometasone cream with either agent alone in the treatment of childhood vitiligo. Journal of Pakistan Association of Dermatology. 28(4). 507–513. 4 indexed citations
2.
Farajzadeh, Saeedeh, et al.. (2016). Clinical and demographic profile of childhood alopecia areata in Iran. Journal of Pakistan Association of Dermatology. 23(1). 20–27. 3 indexed citations
3.
Esfandiarpour, Iraj, et al.. (2016). Pattern of cutaneous disorders in the South Eastern Iran, Kerman. Journal of Pakistan Association of Dermatology. 25(1). 18–22.
4.
Esfandiarpour, Iraj, et al.. (2014). THE EFFICACY OF CARBON DIOXIDE LASER IN THE TREATMENT OF CHRONIC AND LUPOID CUTANEOUS LEISHMANIASIS IN KERMAN CITY: A RANDOMIZED CLINICAL TRIAL. SHILAP Revista de lepidopterología. 21(4). 267–276. 3 indexed citations
5.
Esfandiarpour, Iraj, et al.. (2012). Adverse effects of intralesional meglumine antimoniate and its influence on clinical laboratory parameters in the treatment of cutaneous leishmaniasis. International Journal of Dermatology. 51(10). 1221–1225. 20 indexed citations
6.
Farajzadeh, Saeedeh, et al.. (2010). EVALUATION OF LIPID PROFILE IN WOMEN WITH FEMALE PATTERN ALOPECIA. 13(353). 78–81. 1 indexed citations
7.
Esfandiarpour, Iraj. (2009). Necrobiosis Lipoidica Diabeticorum of the Scalp: A Case Report. 12(3). 93–95. 1 indexed citations
8.
Farajzadeh, Saeedeh, et al.. (2009). The relationship between infantile atopic dermatitis and urinary tract infection.. PubMed. 8(4). 211–4. 4 indexed citations
9.
10.
Mousavi, Seyyed Amin Ayatollahi, Iraj Esfandiarpour, Samira Salari, & Hojjatollah Shokri. (2009). Onychomycosis due to Fusarium spp. in patient with squamous cell carcinoma: A case report from Kerman, Iran. Journal de Mycologie Médicale. 19(2). 146–149. 8 indexed citations
11.
Esfandiarpour, Iraj, et al.. (2008). FREQUENCY OF CLINICAL VARIANTS OF LICHEN PLANUS IN DERMATOLOGY OUT-PATIENTS IN KERMAN. 10(442). 283–289.
12.
Esfandiarpour, Iraj, et al.. (2008). KOEBNERIZATION IN A WOMAN WITH EXTRAGENITAL LICHEN SCLEROSUS. 11(244). 86–88.
13.
Esfandiarpour, Iraj, et al.. (2008). FREQUENCY OF SKIN DISEASES IN CHILDREN IN KERMAN. 10(442). 320–328. 3 indexed citations
14.
Kashani, Mansour Nassiri, et al.. (2007). FREQUENCY OF CONTACT SENSITIZATION TO EUROPEAN STANDARD SERIES (ESS) IN CONTACT AND/OR ATOPIC DERMATITIS PATIENTS IN RASHT, AHWAZ, KERMAN AND HAMEDAN. 10(341). 187–195. 1 indexed citations
15.
Esfandiarpour, Iraj & Shahriar Dabiri. (2007). Treatment of cutaneous leishmaniasis recidivans with a combination of allopurinol and meglumine antimoniate: a clinical and histologic study. International Journal of Dermatology. 46(8). 848–852. 22 indexed citations
16.
Esfandiarpour, Iraj, et al.. (2005). The Prevalence of Hepatitis C Antibody in Psoriatic Patients in KermanThe Prevalence of Hepatitis C Antibody in Psoriatic Patients in Kerman. SHILAP Revista de lepidopterología. 2 indexed citations
17.
Esfandiarpour, Iraj, et al.. (2005). THE PREVALENCE OF HEPATITIS C ANTIBODY IN PSORIATIC PATIENTS IN KERMAN. 12(135). 5–9. 1 indexed citations
18.
Esfandiarpour, Iraj, et al.. (2004). The relationship between lichen planus and hepatitis C in dermatology outpatients in Kerman, Iran. International Journal of Dermatology. 44(9). 746–748. 28 indexed citations
19.
Esfandiarpour, Iraj, et al.. (2003). FREQUENCY OF DEPRESSION IN PATIENTS SUFFERING FROM VITILIGO. 3(323). 13–18. 4 indexed citations
20.
Esfandiarpour, Iraj & Afsáneh Alavi. (2002). Evaluating the efficacy of allopurinol and meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis. International Journal of Dermatology. 41(8). 521–524. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zabihollah Shahmoradi Breakdown of academic impact, for papers by Orhan Özgöztaşı Breakdown of academic impact, for papers by A.J. Kanwar Breakdown of academic impact, for papers by Robert Guy Breakdown of academic impact, for papers by YogeshS Marfatia Breakdown of academic impact, for papers by Wendy C. Cantrell Breakdown of academic impact, for papers by V. Goffin Breakdown of academic impact, for papers by Izabela Chudzicka-Strugała Breakdown of academic impact, for papers by Ganga Sirimanna Breakdown of academic impact, for papers by Véronique Goffin
Rankless by CCL
2026